Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Industry 360° synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing incidence of neurological disorders
3.2.1.2 Advancements in technology
3.2.1.3 Growing awareness and focus on brain health
3.2.1.4 Rise in research and development activities
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of brain monitoring devices
3.2.2.2 Privacy and ethical concerns
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter’s analysis
3.6.1 Supplier power
3.6.2 Buyer power
3.6.3 Threat of new entrants
3.6.4 Threat of substitutes
3.6.5 Industry rivalry
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product Type, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Devices
5.2.1 Magnetoencephalograph devices
5.2.2 Electroencephalograph
5.2.3 Cerebral oximeters
5.2.4 Functional magnetic resonance imaging (fMRI)
5.2.5 Intracranial pressure monitoring devices
5.2.6 Computerized tomography scanners (CT)
5.2.7 Positron emission tomography (PET)
5.2.8 Sleep monitoring devices
5.2.9 Electromyography devices (EMG)
5.2.10 Transcranial doppler devices (TCD)
5.2.11 Other devices
5.3 Accessories
5.3.1 Electrodes
5.3.2 Sensors
5.3.3 Caps
5.3.4 Cables
5.3.5 Paste or gel
5.3.6 Other accessories
Chapter 6 Market Estimates and Forecast, By Modality, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Fixed
6.3 Portable
6.4 Wearable
Chapter 7 Market Estimates and Forecast, By Type of Procedure, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Invasive
7.3 Non-invasive
Chapter 8 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 Parkinson’s disease
8.3 Traumatic brain injury
8.4 Epilepsy
8.5 Dementia
8.6 Sleep disorders
8.7 Stroke
8.8 Migraine
8.9 Other applications
Chapter 9 Market Estimates and Forecast, By End-use, 2018 – 2032 ($ Mn)
9.1 Key trends
9.2 Hospitals
9.3 Neurology centers
9.4 Diagnostic centers
9.5 Other end-users
Chapter 10 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.5.4 Rest of Latin America
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
10.6.4 Rest of Middle East and Africa
Chapter 11 Company Profiles
11.1 BrainScope Company, Inc.
11.2 Cadwell Industries, Inc.
11.3 Compumedics Limited
11.4 Edwards Lifesciences
11.5 Elekta AB
11.6 GE Healthcare
11.7 Koninklijke Philips N.V.
11.8 Medtronic plc
11.9 Natus Medical Incorporated
11.10 Siemens Healthineers AG
